Zobrazeno 41 - 50
of 62
pro vyhledávání: '"Mohammadi, Ali"'
Autor:
Mohammadi A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran., Mansoori B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran., Baradaran B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Behzad_im@yahoo.com.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2016 Dec; Vol. 84, pp. 705-713. Date of Electronic Publication: 2016 Oct 01.
Autor:
Mansoori B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran E-mail : behzad_im@yahoo.com., Mohammadi A, Shirjang S, Baghbani E, Baradaran B
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2016; Vol. 17 (4), pp. 1887-90.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Behzad Baradaran, Pascal H.G. Duijf, Vahid Khaze, Nicola Silvestris, Behzad Mansoori, Dariush Shanehbandi, Ahad Mokhtarzadeh, Afshin Derakhshani, Ali Mohammadi, Elham Baghbani
Publikováno v:
Mansoori, B, Silvestris, N, Mohammadi, A, Khaze, V, Baghbani, E, Mokhtarzadeh, A, Shanehbandi, D, Derakhshani, A, Duijf, P H G & Baradaran, B 2021, ' Mir-34a and mir-200c have an additive tumor-suppressive effect on breast cancer cells and patient prognosis ', Genes, vol. 12, no. 2, 267 . https://doi.org/10.3390/genes12020267
Genes, Vol 12, Iss 267, p 267 (2021)
Genes
Volume 12
Issue 2
Genes, Vol 12, Iss 267, p 267 (2021)
Genes
Volume 12
Issue 2
Breast cancer is the most common women’s malignancy in the world and, for subgroups ofpatients, treatment outcomes remain poor. Thus, more effective therapeutic strategies are urgently needed. MicroRNAs (miRNAs) have emerged as promising therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1da4cd3ee00607aad2bdf2eb9d530c
https://findresearcher.sdu.dk:8443/ws/files/180184356/Open_Access_Version.pdf
https://findresearcher.sdu.dk:8443/ws/files/180184356/Open_Access_Version.pdf
Autor:
Grith Lykke Sørensen, Behzad Mansoori, Behrooz Shokouhi, Behzad Baradaran, Pascal H.G. Duijf, Leila Tebbi, Souzan Najafi, Ali Mohammadi, Elham Safarzadeh, Uffe Holmskov
Publikováno v:
Mohammadi, A, Mansoori, B, Duijf, P H G, Safarzadeh, E, Tebbi, L, Najafi, S, Shokouhi, B, Sorensen, G L, Holmskov, U & Baradaran, B 2021, ' Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration ', Journal of Cellular Physiology, vol. 236, no. 1, pp. 273-283 . https://doi.org/10.1002/jcp.29840
Lung cancer is one of the most common cancers and its incidence is rising around the world. Various studies suggest that miR-330 acts as a tumor-suppressor microRNA (miRNA) in different types of cancers, but precisely how has remained unclear. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53e57bb14b45618e728ad4af849e219
https://hdl.handle.net/11541.2/34241
https://hdl.handle.net/11541.2/34241
Autor:
Uffe Holmskov, Vahid Khaze, Morten F. Gjerstorff, Behzad Baradaran, Behzad Mansoori, Pascal H.G. Duijf, Souzan Najafi, Solmaz Shirjang, Dariush Shanehbandi, Ali Mohammadi, Sanaz Naghizadeh
Publikováno v:
Mansoori, B, Mohammadi, A, Naghizadeh, S, Gjerstorff, M, Shanehbandi, D, Shirjang, S, Najafi, S, Holmskov, U, Khaze, V, Duijf, P H G & Baradaran, B 2020, ' miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer ', Journal of Cellular Physiology, vol. 235, no. 2, pp. 920-931 . https://doi.org/10.1002/jcp.29007
MicroRNAs (miRNAs) are important molecular regulatorsof cellular signaling and behavior. They alter gene expression by targeting messenger RNAs, including those encoding transcriptional regulators, such as HMGA2. While HMGA2 is oncogenic in various t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3533abaa024cb15bde3321f806369065
https://hdl.handle.net/11541.2/34463
https://hdl.handle.net/11541.2/34463
Autor:
William C. Cho, Elmira Roshani, Pascal H.G. Duijf, Behnaz Mansoori, Pouria Savadi, Behzad Mansoori, Afsaneh Nazari, Ahad Mokhtarzadeh, Ali Mohammadi, Haleh AsadollahSeraj, Behzad Baradaran, Souzan Najafi
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 141, Iss, Pp 111925-(2021)
Mansoori, B, Najafi, S, Mohammadi, A, AsadollahSeraj, H, Savadi, P, Mansoori, B, Nazari, A, Mokhtarzadeh, A, Roshani, E, Duijf, P HG, Cho, W C S & Baradaran, B 2021, ' The synergy between miR-486–5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells ', Biomedicine and Pharmacotherapy, vol. 141, 111925 . https://doi.org/10.1016/j.biopha.2021.111925
Mansoori, B, Najafi, S, Mohammadi, A, AsadollahSeraj, H, Savadi, P, Mansoori, B, Nazari, A, Mokhtarzadeh, A, Roshani, E, Duijf, P HG, Cho, W C S & Baradaran, B 2021, ' The synergy between miR-486–5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells ', Biomedicine and Pharmacotherapy, vol. 141, 111925 . https://doi.org/10.1016/j.biopha.2021.111925
Breast cancer (BC) is the most common type of malignancy in women. A subset of breast cancers show resistance to endocrine-based therapies. The estrogen receptor (ER) plays a critical role in developing hormone-dependent BC. Loss of ER contributes to
Autor:
Henrik J. Ditzel, Behzad Baradaran, Elham Safarzadeh, William C. Cho, Morten F. Gjerstorff, Behzad Mansoori, Pascal H.G. Duijf, Ali Mohammadi
Publikováno v:
Mansoori, B, Duijf, P H G, Mohammadi, A, Safarzadeh, E, Ditzel, H J, Gjerstorff, M F, Cho, W C S & Baradaran, B 2021, ' MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy ', Life Sciences, vol. 276, 119431 . https://doi.org/10.1016/j.lfs.2021.119431
MicroRNAs (miRNAs) have the ability to regulate gene expression programs in cells. Hence, altered expression of miRNAs significantly contributes to breast cancer development and progression. Here, we demonstrate that the miRNA miR-142-3p directly tar
Autor:
Pascal H.G. Duijf, Vahid Montazeri, Ali Mohammadi, Morten F. Gjerstorff, Behzad Mansoori, Solmaz Shirjang, Uffe Holmskov, Razeieh Dehghan, Behzad Baradaran, Tohid Kazemi, Mehri Ghasabi
Publikováno v:
Mansoori, B, Mohammadi, A, Ghasabi, M, Shirjang, S, Dehghan, R, Montazeri, V, Holmskov, U, Kazemi, T, Duijf, P, Gjerstorff, M & Baradaran, B 2019, ' miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression ', Journal of Cellular Physiology, vol. 234, no. 6, pp. 9816-9825 . https://doi.org/10.1002/jcp.27670
Background: Breast cancer is the most common type of cancer among women, and despite improved treatments, it remains a major challenge. However, improved mechanistic insight may lead to novel therapeutic strategies. miR‐142‐3p belongs to the miR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7da364f6977985fd31addb63010696e1
https://hdl.handle.net/11541.2/34374
https://hdl.handle.net/11541.2/34374